Trastuzumab MMAE

Product Description: Trastuzumab MMAE is an anti-human epidermal growth factor receptor 2 (HER2) antibody-drug conjugate (ADC). Trastuzumab MMAE is composed of a humanized anti-HER2 antibody Trastuzumab (HY-P9907), an enzymatically cleavable peptide-linker Valine-citrulline, a tubulin inhibitor Monomethyl auristatin E (MMAE; HY-15162). Trastuzumab MMAE can be used for the research of HER2-positive breast cancer[1].

Applications: Cancer-programmed cell death

Formula: N/A

References: [1]Sajad Yaghoubi, et al. Development and biological assessment of MMAE-trastuzumab antibody-drug conjugates (ADCs). Breast Cancer. 2021 Jan;28(1):216-225.

Molecular Weight: N/A

Compound Purity: 96.02

Research Area: Cancer

Target: Antibody-Drug Conjugates (ADCs);EGFR;Microtubule/Tubulin

• Artikelnummer: MEXHY-164992-1
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-164992-1
• Verpackungseinheit: 1 mg
• Mengeneinheit: STK